类风湿关节炎患者认知障碍风险:一项人群队列研究
结果显示RA患者认知障碍发生率为11.493/1000人年,显著高于对照的9.219/1000人年,调整后SHR为1.222(95%CI 1.171-1.275)。
要点
- RA患者认知障碍发生风险较匹配对照显著升高(调整SHR 1.222)。
- RA患者认知障碍发生率为11.493/1000人年,对照为9.219/1000人年。
- 认知障碍或为RA重要共病,需临床关注和纵向监测。
核心结论
- RA患者发生认知障碍的风险显著高于年龄、性别和索引年匹配的对照人群。
主要发现
- RA患者中2952例(11.17%)发生认知障碍,对照中2388例(9.03%)发生认知障碍。
- RA患者认知障碍发生率为11.493(95%CI 7.648-15.338)/1000人年,对照为9.219(95%CI 5.386-13.052)/1000人年。
- 调整后亚分布风险比(SHR)为1.222(95%CI 1.171-1.275),表明RA患者认知障碍风险显著升高。
关键数值与推荐
- 认知障碍定义采用国际疾病分类第10版编码(F00-F03、F31.82、F06.7、G30和G31.00)。
- 采用多变量分层竞争风险回归分析,将死亡作为竞争风险,估计调整后SHR及95%CI。
临床怎么用
- 临床应提高对RA患者认知障碍这一共病的认识,并考虑进行纵向监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to evaluate the incidence rate and incident cognitive impairment risk in patients with rheumatoid arthritis (RA) compared with matched controls. METHODS: This population-based matched cohort study enrolled patients newly diagnosed with RA (n=26 437) between 2011 and 2014 and 1:1 age-, sex- and index-year-matched controls (n=26 437) from a Korean nationwide claims database. Follow-up spanned the index date to the earliest occurrence of incident cognitive impairment or December 2022. Cognitive impairment was defined using the International Classification of Diseases, 10th Revision, codes (F00-F03, F31.82, F06.7, G30 and G31.00). Incidence rates were calculated as events per 1000 person-years. Multivariable stratified competing risks regression analyses estimated adjusted subdistribution HRs (SHRs) with 95% CIs for incident cognitive impairment, treating death as a competing risk. RESULTS: During the mean respective follow-up of 9.410±2.271 and 9.508±2.217 years, 2952 (11.17%) and 2388 (9.03%) patients with RA and controls developed incident cognitive impairment, respectively. The cognitive impairment incidence rates in patients with RA and controls were 11.493 (95% CI 7.648 to 15.338) and 9.219 (95% CI 5.386 to 13.052) per 1000 person-years, respectively. Compared with the control individuals, patients with RA had a significantly higher risk of developing cognitive impairment (adjusted SHR, 1.222 (95% CI 1.171 to 1.275)). CONCLUSIONS: These findings suggest that cognitive impairment may represent an important comorbidity in patients with RA that merits clinical awareness and longitudinal monitoring.
引用
- Kwon OC, Lee HS, Yang HJ, et al. Cognitive impairment risk in patients with rheumatoid arthritis: a population-based cohort study. RMD Open. 2026. PMID: 42049395. doi:10.1136/rmdopen-2025-006685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。